We describe the phenotype of a Bulgarian early-onset Alzheimer’s disease (EOAD) family with 3 affected patients in 3 generations. In the proband, a novel L381V mutation in the presenilin1 (PSEN1) gene was identified. In this patient, the first symptoms were noticed at the age of 32 years and she died at the age of 37 years. The EOAD phenotype caused by the novel L381V mutation in the PSEN1 gene presented clinically, by a very early onset in the proband, rapid progression of dementia, spastic paraparesis, and extrapyramidal signs, as atypical clinical signs in Alzheimer’s disease patients.
Goate A., Chartier-Harlin MC, Mullan M., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature . 1991;349(6311):704-706.
2.
Sherrington R., Rogaev EI, Liang Y., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature. 1995;375(6534):754-760.
3.
Levy-Lahad E. , Wasco W., Poorkaj P., et al. Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science. 1995;269(5226):973-977.
4.
Filley CM, Rollins YD, Anderson CA, et al. The genetics of very early onset Alzheimer disease. Cogn Behav Neurol. 2007;20(3):149-156.
5.
Rosenberg RNThe molecular and genetic basis of AD: the end of beginning: the 2000 Wartenberg lecture. Neurology. 2000;54(11):2045-2054.
6.
Cruts M., Van Broeckhoven C.Presenilin mutations in Alzheimer’s disease. Hum Mutat . 1998;11(3):183-190.
7.
Cruts M., Van Duijn CM, Backhovens H., et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet. 1998;7(1):43-51.
8.
Mehrabian S. , Traykov L., Jordanova A., Raycheva M., Petrova M., Jelev Y. Comparison of neuropsychological studies in patients with Alzheimer’s disease depending on Apolipoprotein E genotype. Bulgarian Neurology. 2008;8(2):51-56.
9.
Barret A.A case of Alzheimer’s disease with unusual neurological disturbances . J Nervous Mental Disorder. 1913;4c(2):361-64.
10.
Van Bogaert L., Maere M., De Smedt E.Sur les formes familiales precoces de la maladie d ‘Alzheimer. Monatsschrift Psychiatr Neurol. 1940;102(5):249-301.
11.
Kwok JB, Taddei K., Hallupp M., et al. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer’s disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. NeuroReport . 1997;8(6):1537-1542.
12.
Lippa CF, Fujiwara H., Mann DM, et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer’s disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol. 1998;153(5):1365-1370.
13.
Houlden H., Crook R., Dolan RJ, et al. A novel presenilin mutation (M233V) causing very early onset Alzheimer’s disease with Lewy bodies. Neurosci Lett . 2001;313(1-2): 93-95.
14.
Yokota O., Terada S., Ishizu H., et al. NACP/alphasynuclein, NAC, and beta-amyloid pathology of familial Alzheimer’s disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases. Acta Neuropathol ( Berl). 2002;104(6):637-648.
